MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 8, 2014, Pages 3767-3772

  Xiang, Kai Min ^a   Li, Xiao Rong ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Colon cancer cells; microRNA 133b; TBP like 1

Indexed keywords

MESSENGER RNA; MICRORNA; MIRN133 MICRORNA, HUMAN; SMALL INTERFERING RNA; TATA BINDING PROTEIN RELATED FACTOR; TBPL1 PROTEIN, HUMAN;

ADENOCARCINOMA; CELL PROLIFERATION; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; HUMAN; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TATA BOX BINDING PROTEIN-LIKE PROTEINS;

EID: 84901999612     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.8.3767     Document Type: Article

References (25)

1. Aghili M, Izadi S, Madani H, et al (2010). Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer. Asia Pac J Clin Oncol, 6, 35-41.
2. Ambros V (2004). The functions of animal microRNAs. Nature, 431, 350-5.
3. Ayude D, Rodriguez-Berrocal FJ, Ayude J, et al (2013). Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer. BMC Cancer, 13, 543.
4. Bandres E, Cubedo E, Agirre X, et al (2006). Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol cancer, 5, 29.
5. Dantonel JC, Wurtz JM, Poch O, et al (1999). The TBP-like factor: an alternative transcription factor in metazoa? Trends Biochem Sci, 24, 335-9.
6. Ehrig K, Kilinc MO, Chen NG, et al (2013). Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68. J Transl Med, 11, 79.
7. Esquela-Kerscher A, Slack FJ (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69.
8. Farh KK, Grimson A, Jan C, et al (2005). The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science, 310, 1817-21.
9. Fetemeh H, Saeed A, Amir M, Mehdi E (2014). Clinicopathological features of colon adenocarcinoma in Qazvin, Iran: a 16 year study. Asian Pac J Cancer Prev, 15, 951-5.
10. Jacobi UG, Akkers RC, Pierson ES, et al (2007). TBP paralogs accommodate metazoan- and vertebrate-specific developmental gene regulation. EMBO J, 26, 3900-9.
11. Koutsoulidou A, Mastroyiannopoulos NP, Furling D, et al (2011). Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Dev Biol, 11, 34.
12. Lim LP, Lau NC, Garrett-Engele P, et al (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-73.
13. Lim LP, Lau NC, Weinstein EG, et al (2003). The microRNAs of Caenorhabditis elegans. Genes Dev, 17, 991-1008.
14. Lin M, Chen W, Huang J, et al (2011). MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol Rep, 25, 739-47.
15. Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.
16. Martianov I, Brancorsini S, Gansmuller A, et al (2002). Distinct functions of TBP and TLF/TRF2 during spermatogenesis: requirement of TLF for heterochromatic chromocenter formation in haploid round spermatids. Development, 129, 945-55.
17. Novello C, Pazzaglia L, Cingolani C, et al (2013). miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. Int J Oncol, 42, 667-75.
18. Panguluri SK, Bhatnagar S, Kumar A, et al (2010). Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice. PloS One, 5, e8760.
19. Schickel R, Boyerinas B, Park SM, et al (2008). MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene, 27, 5959-74.
20. Sun K, Deng HJ, Lei ST, et al (2013). miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened. World J Gastroenterol, 19, 2197-207.
21. Vannini A, Cramer P (2012). Conservation between the RNA polymerase I, II, and III transcription initiation machineries. Mol Cell, 45, 439-46.
22. Wen D, Li S, Ji F, et al (2013). miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer. Tumour Biol, 34, 793-803.
23. Yamamoto H, Kohashi K, Fujita A, et al (2013). Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromal tumor. Mod Pathol, 26, 563-71.
24. Yamasaki T, Yoshino H, Enokida H, et al (2012). Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. Int J Oncol, 40, 1821-30.
25. Zhou Y, Wu D, Tao J, et al (2013). MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer. Scand J Urol, 47, 423-32.